1.
Saygin C, Cannova J, Stock W, Muffly L. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. haematol [Internet]. 2022Dec.1 [cited 2024Jun.18];107(12):2783-9. Available from: https://haematologica.org/article/view/haematol.2022.280638